Clinical Trial

TDCS Stimulation After Covid-19 Infection

Recruiting
View on ClinicalTrials.gov →
Summary
In this study, the effects of bilateral stimulation of the dorsolateral prefrontal cortex (DLPFC) with active tDCS (transcranial direct stimulation/transcranial direct stimulation) on neurocognitive (memory and executive) functions in patients with Covid-19 infection and subjective cognitive complaints, as well as resting-state fMRI In the case of dfMRI, it is aimed to examine the default mode network (DMN) and parietal memory network (PMN) inter- and intra-network connectivity alterations and the hippocampal region connectivity alterations and contribute to the relevant literature.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-12-25.
Trial Details
NCT Number NCT06183424
Lead Sponsor Istanbul Medipol University Hospital
Collaborators: Alanya Alaaddin Keykubat University
Conditions COVID-19
Enrollment 50 participants
Start Date 2023-10-01
Primary Completion 2024-10-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-02